Blue-light filtering intraocular lenses (IOLs) for protecting macular health.
CONCLUSIONS: This systematic review shows with moderate certainty that there is no clinically meaningful difference in short-term BCVA with the two types of IOLs. Further, based upon available data, these findings suggest that there is no clinically meaningful difference in short-term contrast sensitivity with the two interventions, although there was a low level of certainty for this outcome due to a small number of included studies and their inherent risk of bias. Based upon current, best-available research evidence, it is unclear whether blue-light filtering IOLs preserve macular health or alter risks associated with the development and progression of AMD, or both. Further research is required to fully understand the effects of blue-light filtering IOLs for providing protection to macular health and function.
PMID: 29786830 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Downie LE, Busija L, Keller PR Tags: Cochrane Database Syst Rev Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Cataract Removal | Cataracts | Databases & Libraries | Eyes | General Medicine | Study | Vitamin A